Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development

Thromb Haemost. 2020 Feb;120(2):344-347. doi: 10.1055/s-0039-3400746. Epub 2019 Dec 14.

Emiel P C van der Vorst^{1

2

3

4}, Isabelle Daissormont¹, Maria Aslani⁴, Tom Seijkens⁵, Erwin Wijnands¹, Esther Lutgens^{4

5}, Johan Duchene⁴, Donato Santovito⁴, Yvonne Döring^{4

6}, Bente Halvorsen⁷, Pal Aukrust⁷, Christian Weber^{4

6

8}, Uta E Höpken⁹, Erik A L Biessen^{1

2}

¹ Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
² Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
³ Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, Aachen, Germany.
⁴ Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany.
⁵ Department of Medical Biochemistry, Amsterdam University Medical University, Amsterdam, The Netherlands.
⁶ DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
⁷ Research Institute of Internal Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway.
⁸ Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
⁹ Department of Microenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany.

No abstract available

MeSH terms